NICE releases guidance for the use of biologics in the treatment of RA

NICE releases guidance for the use of biologics in the treatment of RA

The recommendations replace technology appraisal guidance previously issued by the institute related to adalimumab, etanercept, infliximab and certolizumab pegol for the treatment of rheumatoid arthritis (RA); golimumab for methotrexate-na├»ve RA; and …

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.